novo

Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd,[3] with production facilities in nine countries and affiliates or offices in five. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S (wholly owned by the Novo Nordisk Foundation) which holds approximately 28.1% of its shares and a majority (77.1%) of its voting shares.[4]